Rangan Chatterjee is a British physician, author, television presenter and podcaster. He is best known for his TV show Doctor in the House and for being the resident doctor on BBC Breakfast and as a regular contributor to BBC Radio.[1]
Chatterjee's father, Tarun Chatterjee, came to England from Kolkata, India in the 1960s and was a consultant in genito-urinary medicine at Manchester Royal Infirmary.[2] Chatterjee was a pupil at Manchester Grammar School from 1988 to 1995; then he attended the University of Edinburgh, where he studied Medicine and graduated in 2001 with an additional degree in immunology.[3]
Chatterjee hosts the podcast "Feel Better, Live More," and has appeared on BBC Radio as a regular commentator.[4] In 2017 he came 8th in the Pulse Power 50 list of influential GPs.[5] [neutrality is disputed]
\r\n\tLolita Chatterjee, MD is a board-certified primary care doctor at Mount Sinai Doctors, seeing patients Monday - Friday in Midtown. Trained in New Jersey and Connecticut, she is certified by the American Board of Internal Medicine and a fellow of the American College of Physicians. She was awarded her medical degree from Robert Wood Johnson Medical School, now Rutgers Medical School, and completed her residency and internship in Internal Medicine at Yale-New Haven Hospital. She has interest focusing in preventative care, cancer screenings ,hypertension , Diabetes, hypothyroidism, hyperlipidemia, obesity, osteoporosis, smoking cessations and other medical conditions in Internal medicine., as well as, routinely attending nationally recognized medical conferences and seminars.
Lolita Chatterjee, MD is a board-certified primary care doctor at Mount Sinai Doctors, seeing patients Monday - Friday in Midtown. Trained in New Jersey and Connecticut, she is certified by the American Board of Internal Medicine and a fellow of the American College of Physicians. She was awarded her medical degree from Robert Wood Johnson Medical School, now Rutgers Medical School, and completed her residency and internship in Internal Medicine at Yale-New Haven Hospital. She has interest focusing in preventative care, cancer screenings ,hypertension , Diabetes, hypothyroidism, hyperlipidemia, obesity, osteoporosis, smoking cessations and other medical conditions in Internal medicine., as well as, routinely attending nationally recognized medical conferences and seminars.
Dr. Soumya Chatterjee, MD, MS, FRCP(UK), FACP, FACR is a Staff Physician in the Orthopedic and Rheumatologic Institute at the Cleveland Clinic. He is also a Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is board-certified in rheumatology and is a fellow of the American College of Physicians, the American College of Rheumatology, and the Royal College of Physicians of the United Kingdom. Dr. Chatterjee joined the medical staff in the Department of Rheumatic and Immunologic Diseases at the Cleveland Clinic in 2004, following a faculty appointment at Wayne State University, Detroit, Michigan. Dr. Chatterjee brings with him extensive clinical experience in rheumatology and internal medicine. After his undergraduate and postgraduate medical training in India, he had further postgraduate training in internal medicine in the United Kingdom. His former training in rheumatology was also in the United Kingdom, where he completed 3 years of rheumatology fellowship training after obtaining Membership of the Royal College of Physicians in 1993. His training in the US was at Wayne State University, Detroit, Michigan where he completed an internal medicine residency, chief residency in internal medicine, and then his second fellowship in rheumatology. In 2003, he also obtained a Master of Science degree in Clinical Research Design and Statistical Analysis from the School of Public Health of the University of Michigan. Dr. Chatterjee is a general rheumatologist who sees patients with complex, multisystem rheumatologic conditions. He takes care of patients with rheumatoid arthritis, lupus, and myositis. His special interest is in scleroderma (systemic sclerosis). In 2005, the Cleveland Clinic Scleroderma Program was established under his leadership, and he has been involved in several research projects in scleroderma. He also participates in a weekly rheumatology-pulmonary combined clinic where patients with various autoimmune rheumatologic diseases (such as scleroderma, lupus, polymyositis, rheumatoid arthritis, etc.) who have pulmonary complications (interstitial lung disease or pulmonary hypertension) are evaluated and managed, in conjunction with two pulmonologists. Dr. Chatterjee enjoys and spends considerable time teaching and mentoring internal medicine residents and rheumatology fellows. He was awarded 'Teacher of the Year' by the Cleveland Clinic rheumatology fellows in 2006, 2010, 2017, and 2022.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/25/2024, Dr. Chatterjee has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
2024 The Cleveland Clinic Foundation. All Rights Reserved. No part of this work may be altered, reproduced, stored in a retrieval system, or transmitted, in any form, by any means, whether electronic, mechanical, by photocopying, recording, or otherwise, without the prior written permission of the Cleveland Clinic.
Dr. Shelly Chatterjee Choudhury is a pediatric gastroenterologist who cares for children with digestive illnesses. She has special interests in eosinophilic gastrointestinal disorders (inflammatory digestive tract conditions linked to food allergies) and aerodigestive disorders.
In research, Choudhury has studied noninvasive techniques for diagnosing eosinophilic esophagitis (an allergic condition of the esophagus) as well as new treatments for the disease, including biologics (medications derived from living sources).
Choudhury earned her medical degree from Nil Ratan Sircar Medical College and Hospital in India. She completed a residency in pediatrics at BronxCare Health System and a fellowship in pediatric gastroenterology at University at Buffalo, part of the State University of New York system.
c80f0f1006